{56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy]
varenicline
RxCUI: 795735
What the CMS Formulary Data Shows for {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy]
Per the CMS 2026 Part D formulary file, {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] (RxNorm concept RXCUI 795735, generic name varenicline) appears on 1 distinct formulary file spanning 4 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 4 to Tier 4, with a cross-plan average of Tier 4.
Real-world access to {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 136 Part D beneficiaries filled {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] in 2023, with total plan-and-beneficiary spending of $88,399 and an average per-beneficiary annual cost of $649.99. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 4
- Coverage rate
- 0.1%
- Tier range
- Tier 4, Non-Preferred
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 136
- Total spending
- $88,399
- Avg per beneficiary
- $649.99
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy]
4 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Health New England Medicare Compass (PPO) | HEALTH NEW ENGLAND, INC. | T4 | No | $0 | MA |
| Health New England Medicare Value (HMO) | HEALTH NEW ENGLAND, INC. | T4 | No | $0 | MA |
| Health New England Medicare Premium (HMO) | HEALTH NEW ENGLAND, INC. | T4 | No | $15.80 | MA |
| Health New England Medicare Plus (HMO) | HEALTH NEW ENGLAND, INC. | T4 | No | $58.40 | MA |
Frequently Asked Questions
Is {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] covered by Medicare Part D?
Yes, {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] is covered by 4 Medicare Part D plans (0.1% of all Part D formularies).
What tier is {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] on Medicare Part D plans?
{56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] averages Tier 4 across Part D plans, ranging from Tier 4 to Tier 4.
Does {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] require prior authorization?
0% of Part D formularies require prior authorization for {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy]. Step therapy: 0%. Quantity limits: 100%.
How much does Medicare spend on {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy]?
In 2023, total Medicare Part D spending on {56 (varenicline 1 MG Oral Tablet [Chantix]) } Pack [Chantix Continuing Months Of Therapy] was $88,399, covering 136 beneficiaries. The average spend per beneficiary was $649.99.
Read our methodology - how this data is sourced, computed, and verified.